Jeet S. Sidhu
Keine laufenden Positionen mehr
Karriereverlauf von Jeet S. Sidhu
Ehemalige bekannte Positionen von Jeet S. Sidhu
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
CERES VENTURES, INC. | Direktor/Vorstandsmitglied | 07.06.2010 | 15.08.2012 |
Independent Dir/Board Member | 03.06.2010 | 15.08.2012 | |
RENOVACARE, INC. | Direktor/Vorstandsmitglied | 12.09.2008 | 26.08.2010 |
Montgomery Asset Management Corp.
Montgomery Asset Management Corp. Investment ManagersFinance Montgomery Asset Management Corp. provides financial consulting services. The company is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 01.01.2002 | 01.01.2009 |
EMERGENT ENERGY CORP. | Direktor/Vorstandsmitglied | 01.08.2006 | 01.08.2006 |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Direktor/Vorstandsmitglied | 15.01.2001 | - |
MicroChannel Technologies Corp.
MicroChannel Technologies Corp. Financial ConglomeratesFinance MicroChannel Technologies Corp. is a development stage company. It is not engaged in any business operations. The company was founded on February 28, 2005 and is headquartered in Fort Lauderdale, FL. | Direktor/Vorstandsmitglied | 09.09.2010 | - |
Independent Dir/Board Member | 22.09.2011 | - |
Statistik
International
Vereinigte Staaten | 5 |
Kanada | 3 |
Operativ
Director/Board Member | 5 |
Independent Dir/Board Member | 2 |
Corporate Officer/Principal | 1 |
Sektoral
Health Services | 3 |
Finance | 3 |
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
RENOVACARE, INC. | Health Technology |
CERES VENTURES, INC. | Health Services |
Private Unternehmen | 4 |
---|---|
Montgomery Asset Management Corp.
Montgomery Asset Management Corp. Investment ManagersFinance Montgomery Asset Management Corp. provides financial consulting services. The company is headquartered in Vancouver, Canada. | Finance |
MicroChannel Technologies Corp.
MicroChannel Technologies Corp. Financial ConglomeratesFinance MicroChannel Technologies Corp. is a development stage company. It is not engaged in any business operations. The company was founded on February 28, 2005 and is headquartered in Fort Lauderdale, FL. | Finance |
Emergent Energy Corp.
Emergent Energy Corp. Contract DrillingIndustrial Services Emergent Energy Corp. engages in acquiring oil and gas prospects. The company was founded on July 24, 1998 and is headquartered in Vancouver, Canada. | Industrial Services |
HepaLife Technologies, Inc.
HepaLife Technologies, Inc. Medical/Nursing ServicesHealth Services Alliqua, Inc. is a biomedical products company focused on the development and manufacturing of proprietary technologies in the fields of drug delivery, advanced wound care and liver health preservation. It intends to develop active ingredient and transdermal drug delivery products, primarily utilizing the proprietary hydrogel technology platform manufactured by its subsidiary AquaMed Technologies, Inc. The firm develops HepaMate, an extracorporeal cell-based bioartificial liver system designed to combine blood detoxification with liver cell therapy to provide whole liver function in patients with the most severe forms of liver failure. Its HepaMate is comprised of a blood plasma separation cartridge, a hollow-fiber bioreactor filled with proprietary porcine liver cells, a charcoal column, an oxygenator, circuit tubing and a plasma reservoir. The company was founded on October 21, 1997 and is headquartered in New York, NY. It changed its name from HepaLife Technologies, Inc. in January 2011. | Health Services |
- Börse
- Insiders
- Jeet S. Sidhu
- Erfahrung